Reduction of mean arterial pressure and proteinuria by the effect of ACEIs (Lisinopril) in Kurdish hypertensive patients in Hawler City
| Autor: | Muslih Ai |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Male
medicine.medical_specialty Mean arterial pressure hypertension MAP: mean arterial pressure Angiotensin-Converting Enzyme Inhibitors Blood Pressure Urinalysis Excretion chemistry.chemical_compound ARB: angiotensin receptor blockers Internal medicine medicine RAS: renin-angiotesnsin system Humans kurdish race Antihypertensive Agents Creatinine Proteinuria biology business.industry lisinopril Lisinopril Angiotensin-converting enzyme General Medicine Articles ACEIs: angiotensin converting enzyme inhibitors medicine.disease CRI: chronic renal insufficiency Blood pressure chemistry Heart failure Iraq ESRD: end-stage renal disease Cardiology biology.protein Female medicine.symptom business medicine.drug circulatory and respiratory physiology ACEI |
| Zdroj: | Global Journal of Health Science |
| ISSN: | 1916-9736 |
| Popis: | The angiotensin converting enzyme inhibitors (ACEIs) are a group of pharmaceuticals that are used primarily in treatment of hypertension and congestive heart failure, in some cases as the drugs of first choice. The renin-angiotensin system is activated in response to hypotension, decreased sodium concentration in the distal tubule, decreased blood volume and in renal sympathetic nerve stimulation. This study examines the effects of angiotensin converting enzyme inhibitor (Lisinopril) on blood pressure (BP) 131 ± 2.4 and proteinuria 0.198 ± 0.005 in Kurd hypertensive patients, mean arterial blood pressure and proteinuria excretion were measured weekly along the period of 12 weeks. Lisinopril significantly reduced mean arterial blood pressure, and attenuated proteinuria level in patients subjected to this study in lisinopril 10mg dose dependent manner (p0.05, n=24). In conclusion, lisinopril is of beneficial of renoprotection and in lowering BP. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|